During the seminar, titled “Improving Patient Outcomes: Bridging the Gap Between Science and Efficacy,” each member of the SAB presented their most recent findings to the approximately 800 attendees of the international symposium.
Kara Kopplin, senior director of efficacy and research for ROHO Inc, convened the annual meeting of the SAB and ROHO, with expanded participation from throughout the Permobil family: Hrvoje Medic, regional manager; Arne Comperolle, regional training manager; Dan Hughes, director of marketing for ROHO; and Darren Hammond, senior director of ROHO Institute, Continuing Education and Research.
The forum allowed the SAB and other business units of Permobil to share their expertise across academia, industry and clinical care areas to enhance collective knowledge and further the science and prevention of injuries for those who use wheelchairs for mobility, explains a media release from ROHO Inc.
The ROHO SAB was formed in 2014 and is chaired by Dr. Amit Gefen, Tel Aviv University, Israel. Members include Dr Dan Bader, University of South Hampton, United Kingdom; Dr Cees Oomens, Eindhoven University of Technology, the Netherlands; Dr Joyce Black, University of Nebraska; and Dr David Brienza, University of Pittsburgh.
[Source: ROHO Inc]